{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:31:19Z","timestamp":1756636279026},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":7068,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1023\/a:1008362714023","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"1197-1200","source":"Crossref","is-referenced-by-count":33,"title":["Inflammatory demyelinating polyneuropathy: A complication of immunotherapy in malignant melanoma"],"prefix":"10.1016","volume":"11","author":[{"given":"D.A.","family":"Anthoney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.R.J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008362714023_bib0005","series-title":"Brain's Diseases of the Nervous System","first-page":"604","article-title":"Disorders of peripheral nerves","author":"Walton","year":"1993"},{"key":"10.1023\/A:1008362714023_bb0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"10.1023\/A:1008362714023_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mus.880120602","article-title":"Acquired inflammatory demyelinating polyneuropathy: Clinical and electrodiagnostic features","volume":"12","author":"Albers","year":"1989","journal-title":"Muscle Nerve"},{"key":"10.1023\/A:1008362714023_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp.60.2.188","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with carcinoma","volume":"60","author":"Antoine","year":"1996","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1023\/A:1008362714023_bb0020","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.46.3.822","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma","volume":"46","author":"Bird","year":"1996","journal-title":"Neurology"},{"key":"10.1023\/A:1008362714023_bb0025","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1212\/WNL.51.6.1738","article-title":"Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma","volume":"51","author":"Weiss","year":"1998","journal-title":"Neurology"},{"key":"10.1023\/A:1008362714023_bb0030","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1471-4159.1986.tb00795.x","article-title":"Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of melanoma cells","volume":"47","author":"Noronha","year":"1986","journal-title":"J Neurochem"},{"key":"10.1023\/A:1008362714023_bb0035","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/1097-0142(19890315)63:6<1166::AID-CNCR2820630621>3.0.CO;2-5","article-title":"Gangliosides of human melanoma","volume":"63","author":"Tsuchida","year":"1989","journal-title":"Cancer"},{"key":"10.1023\/A:1008362714023_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02071529","article-title":"Active immunotherapy with viral lysates of micrometastases following surgical removal of high-risk melanoma","volume":"16","author":"Hersey","year":"1992","journal-title":"World J Surg"},{"key":"10.1023\/A:1008362714023_bb0045","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1212\/WNL.44.12.2404","article-title":"Demyelinating polyneuropathies trigerred by melanoma immunotherapy","volume":"44","author":"Fuller","year":"1994","journal-title":"Neurology"},{"key":"10.1023\/A:1008362714023_bb0050","first-page":"4342","article-title":"Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma","volume":"52","author":"Saleh","year":"1992","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008362714023_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(97)05390-2","article-title":"Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy","volume":"149","author":"Yuki","year":"1997","journal-title":"J Neurol Sei"},{"key":"10.1023\/A:1008362714023_bb0060","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp.58.5.638","article-title":"Interferon-\u03b1 may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy (Letter)","volume":"58","author":"Sabatelli","year":"1995","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1023\/A:1008362714023_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.50.1.84","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-\u03b1-2a","volume":"50","author":"Gorson","year":"1998","journal-title":"Neurology"},{"key":"10.1023\/A:1008362714023_bb0070","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0277-5379(90)90275-X","article-title":"Primary hypothyroidism associated with interleukin-2 and interferon-\u03b1-2 therapy of melanoma and renal carcinoma","volume":"26","author":"Scalzo","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008362714023_bb0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9343(92)90278-J","article-title":"Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-\u03b1 therapy for metastatic carcinoma: A case report","volume":"92","author":"Sauter","year":"1992","journal-title":"Am J Med"},{"key":"10.1023\/A:1008362714023_bb0080","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0168-8278(98)80328-0","article-title":"Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis","volume":"28","author":"Fabris","year":"1998","journal-title":"J Hepatol"},{"key":"10.1023\/A:1008362714023_bb0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000112905","article-title":"Myasthenia gravis following IFN-\u03b1-2a treatment","volume":"38","author":"Bora","year":"1997","journal-title":"Eur Neurol"},{"key":"10.1023\/A:1008362714023_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-128-5-199803010-00015","article-title":"Dermatologie disease during interferon-\u03b1 therapy for chronic viral hepatits","volume":"128","author":"Dalekos","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1023\/A:1008362714023_bb0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.286.6361.262","article-title":"Neurological effects of recombinant human interferon","volume":"286","author":"Smedley","year":"1983","journal-title":"BMJ"},{"key":"10.1023\/A:1008362714023_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archneur.1997.00550190093020","article-title":"An unusual axonal polyneuropathy induced by low-dose interferon-\u03b1-2a","volume":"54","author":"Rutkove","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1023\/A:1008362714023_bb0105","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jnnp.65.4.604","article-title":"Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-\u03b1","volume":"65","author":"Marzo","year":"1998","journal-title":"J Neurol Neurosurg Psychiatr"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420312096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420312096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/9\/1197\/19478655\/11-9-1197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:37:20Z","timestamp":1582166240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420312096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0923753420312096"],"URL":"https:\/\/doi.org\/10.1023\/a:1008362714023","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}